9-134048349-T-G
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_007371.4(BRD3):c.820A>C(p.Lys274Gln) variant causes a missense change. The variant allele was found at a frequency of 0.0000169 in 1,599,194 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_007371.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
BRD3 | NM_007371.4 | c.820A>C | p.Lys274Gln | missense_variant | Exon 6 of 12 | ENST00000303407.12 | NP_031397.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
BRD3 | ENST00000303407.12 | c.820A>C | p.Lys274Gln | missense_variant | Exon 6 of 12 | 1 | NM_007371.4 | ENSP00000305918.6 | ||
BRD3 | ENST00000371834.6 | c.820A>C | p.Lys274Gln | missense_variant | Exon 6 of 10 | 1 | ENSP00000360900.2 | |||
BRD3 | ENST00000494743.1 | n.160A>C | non_coding_transcript_exon_variant | Exon 2 of 2 | 3 |
Frequencies
GnomAD3 genomes AF: 0.0000920 AC: 14AN: 152218Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000502 AC: 12AN: 239072Hom.: 0 AF XY: 0.0000383 AC XY: 5AN XY: 130408
GnomAD4 exome AF: 0.00000898 AC: 13AN: 1446976Hom.: 0 Cov.: 35 AF XY: 0.00000972 AC XY: 7AN XY: 720196
GnomAD4 genome AF: 0.0000920 AC: 14AN: 152218Hom.: 0 Cov.: 33 AF XY: 0.000121 AC XY: 9AN XY: 74370
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.820A>C (p.K274Q) alteration is located in exon 6 (coding exon 5) of the BRD3 gene. This alteration results from a A to C substitution at nucleotide position 820, causing the lysine (K) at amino acid position 274 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at